Rapid response of advanced squamous non-small cell lung cancer with thrombocytopenia after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells

12Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

We present the first clinical evidence of advanced squamous non-small cell lung cancer with severe thrombocytopenia showing dramatic improvement after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells.

Cite

CITATION STYLE

APA

Hui, Z., Zhang, X., Ren, B., Li, R., & Ren, X. (2015). Rapid response of advanced squamous non-small cell lung cancer with thrombocytopenia after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells. Frontiers in Immunology, 6(DEC). https://doi.org/10.3389/fimmu.2015.00633

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free